Cubist Systematic Strategies, LLC Atea Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.31 - $4.04 $198,864 - $242,723	-60,080 Reduced 63.83%	34,045 $112,000
Q1 2024 May 15, 2024	SELL	$3.09 - $4.56 $260,264 - $384,079	-84,228 Reduced 47.23%	94,125 $380,000
Q4 2023 Feb 14, 2024	BUY	$2.8 - $3.35 $109,984 - $131,588	39,280 Added 28.24%	178,353 $543,000
Q3 2023 Nov 14, 2023	BUY	$3.0 - $3.79 $294,243 - $371,726	98,081 Added 239.27%	139,073 $417,000
Q2 2023 Aug 14, 2023	SELL	$3.21 - $5.06 $110,969 - $174,924	-34,570 Reduced 45.75%	40,992 $153,000
Q1 2023 May 15, 2023	BUY	$3.0 - $4.97 $103,314 - $171,156	34,438 Added 83.74%	75,562 $253,000
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.17 $178,889 - $253,735	41,124 New	41,124 $197,000
Q2 2022 Aug 15, 2022	SELL	$5.33 - $8.18 $521,721 - $800,691	-97,884 Reduced 78.6%	26,656 $189,000
Q1 2022 May 16, 2022	SELL	$5.5 - $9.19 $1.66 Million - $2.77 Million	-301,280 Reduced 70.75%	124,540 $899,000
Q4 2021 Feb 14, 2022	BUY	$7.67 - $44.59 $3.2 Million - $18.6 Million	417,795 Added 5206.17%	425,820 $3.81 Million
Q3 2021 Nov 15, 2021	SELL	$21.33 - $35.06 $798,424 - $1.31 Million	-37,432 Reduced 82.35%	8,025 $281,000
Q2 2021 Aug 16, 2021	BUY	$19.22 - $59.08 $779,505 - $2.4 Million	40,557 Added 827.69%	45,457 $976,000
Q1 2021 May 17, 2021	BUY	$41.42 - $88.44 $202,958 - $433,356	4,900 New	4,900 $303,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $281M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.